Skip to content

MapLight Therapeutics, Inc. MPLT Other Income (Expense)

Other Income (Expense) at other companies

Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$53.4M+700%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$542K-7.8%
LBR
LB Pharmaceuticals Inc Common StockLBRX
$3.05M+172%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-$2.84M-177%
Alto Neuroscience logo
Alto NeuroscienceANRO
$901K+77.7%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$7.46M-8.2%

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M
Total debt$5.6M
Total equity$399.8M+285%
Total assets$418.8M

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K
Free cash flow-$51.2M

Valuation

See full
Market cap$1.39B+100%
Enterprise value$1.34B

Returns & leverage

See full
Return on equity-216.8%
Debt / equity
Current ratio22.9×

Where this comes from

Reported directly by MapLight Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MapLight Therapeutics, Inc. 's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MapLight Therapeutics, Inc. 's other income (expense)?
MapLight Therapeutics, Inc. (MPLT) reported other income (expense) of $1.36M in Q1 2026.
How has MapLight Therapeutics, Inc. 's other income (expense) changed year-over-year?
MapLight Therapeutics, Inc. 's other income (expense) increased by 247.7% year-over-year, from $392K to $1.36M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.